The Insulin-Specific T Cells of Nonobese Diabetic Mice Recognize a Weak MHC-Binding Segment in More Than One Form

Wegmann, D. R., G. S. Eisenbarth. 2000. It’s insulin. J. Autoimmun. 15: 286-291.

Jasinski, J. M., G. S. Eisenbarth. 2005. Insulin as a primary autoantigen for type 1A diabetes. Clin. Dev. Immunol. 12: 181-186.

Wegmann, D. R., M. Norbury-Glaser, D. Daniel. 1994. Insulin-specific T cells are a predominant component of islet infiltrates in prediabetic NOD mice. Eur. J. Immunol. 24: 1853-1857.

Wegmann, D. R., R. G. Gill, M. Norbury-Glaser, N. Schloot, D. Daniel. 1994. Analysis of the spontaneous T cell response to insulin in NOD mice. J. Autoimmun. 7: 833-843.

Daniel, D., R. G. Gill, N. Schloot, D. Wegmann. 1995. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur. J. Immunol. 25: 1056-1062.

Daniel, D., D. R. Wegmann. 1996. Intranasal administration of insulin peptide B:9–23 protects NOD mice from diabetes. Annu. NY Acad. Sci. 778: 371-372.

Harrison, L. C., M. Dempsey-Collier, D. R. Kramer, K. Takahashi. 1996. Aerosol insulin induces regulatory CD8 γδ T cells that prevent murine insulin-dependent diabetes. J. Exp. Med. 184: 2167-2174.

Cetkovic-Cvrlje, M., I. C. Gerling, A. Muir, M. A. Atkinson, J. F. Elliott, E. H. Leiter. 1997. Retardation or acceleration of diabetes in NOD/Lt mice mediated by intrathymic administration of candidate β-cell antigens. Diabetes 46: 1975-1982.

French, M. B., J. Allison, D. S. Cram, H. E. Thomas, M. Dempsey-Collier, A. Silva, H. M. Georgiou, T. W. Kay, L. C. Harrison, A. M. Lew. 1997. Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice. Diabetes 46: 34-39.

Jaeckel, E., M. A. Lipes, H. von Boehmer. 2004. Recessive tolerance to preproinsulin 2 reduces but does not abolish type 1 diabetes. Nat. Immunol. 5: 1028-1035.

Nakayama, M., N. Abiru, H. Moriyama, N. Babaya, E. Liu, D. Miao, L. Yu, D. R. Wegmann, J. C. Hutton, J. F. Elliott, G. S. Eisenbarth. 2005. Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature 435: 220-223.

Jasinski, J. M., L. Yu, M. Nakayama, M. M. Li, M. A. Lipes, G. S. Eisenbarth, E. Liu. 2006. Transgenic insulin (B:9–23) T-cell receptor mice develop autoimmune diabetes dependent upon RAG genotype, H-2g7 homozygosity, and insulin 2 gene knockout. Diabetes 55: 1978-1984.

Zekzer, D., F. S. Wong, L. Wen, M. Altieri, T. Gurlo, H. von Grafenstein, R. S. Sherwin. 1997. Inhibition of diabetes by an insulin-reactive CD4 T-cell clone in the nonobese diabetic mouse. Diabetes 46: 1124-1132.

Bergerot, I., G. A. Arreaza, M. J. Cameron, M. D. Burdick, R. M. Strieter, S. W. Chensue, S. Chakrabarti, T. L. Delovitch. 1999. Insulin B-chain reactive CD4+ regulatory T-cells induced by oral insulin treatment protect from type 1 diabetes by blocking the cytokine secretion and pancreatic infiltration of diabetogenic effector T-cells. Diabetes 48: 1720-1729.

Du, W., F. S. Wong, M. O. Li, J. Peng, H. Qi, R. A. Flavell, R. Sherwin, L. Wen. 2006. TGF-β signaling is required for the function of insulin-reactive T regulatory cells. J. Clin. Invest. 116: 1360-1370.

Hausmann, D. H., B. Yu, S. Hausmann, K. W. Wucherpfennig. 1999. pH-dependent peptide binding properties of the type I diabetes-associated I-Ag7 molecule: rapid release of CLIP at an endosomal pH. J. Exp. Med. 189: 1723-1734.

Stratmann, T., V. Apostolopoulos, V. Mallet-Designe, A. L. Corper, C. A. Scott, I. A. Wilson, A. S. Kang, L. Teyton. 2000. The I-Ag7 MHC class II molecule linked to murine diabetes is a promiscuous peptide binder. J. Immunol. 165: 3214-3225.

Yu, B., L. Gauthier, D. H. Hausmann, K. W. Wucherpfennig. 2000. Binding of conserved islet peptides by human and murine MHC class II molecules associated with susceptibility to type I diabetes. Eur. J. Immunol. 30: 2497-2506.

Latek, R. R., A. Suri, S. J. Petzold, C. A. Nelson, O. Kanagawa, E. R. Unanue, D. H. Fremont. 2000. Structural basis of peptide binding and presentation by the type I diabetes-associated MHC class II molecule of NOD mice. Immunity 12: 699-710.

Abiru, N., D. Wegmann, E. Kawasaki, P. Gottlieb, E. Simone, G. S. Eisenbarth. 2000. Dual overlapping peptides recognized by insulin peptide B:9–23 T cell receptor AV13S3 T cell clones of the NOD mouse. J. Autoimmun. 14: 231-237.

Halbout, P., J. P. Briand, C. Becourt, S. Muller, C. Boitard. 2002. T cell response to preproinsulin I and II in the nonobese diabetic mouse. J. Immunol. 169: 2436-2443.

Lacy, P. E., M. Kostianovsky. 1967. Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 16: 35-39.

Suri, A., I. Vidavsky, K. van der Drift, O. Kanagawa, M. L. Gross, E. R. Unanue. 2002. In APCs, the autologous peptides selected by the diabetogenic I-Ag7 molecule are unique and determined by the amino acid changes in the P9 pocket. J. Immunol. 168: 1235-1243.

Suri, A., J. J. Walters, M. L. Gross, E. R. Unanue. 2005. Natural peptides selected by diabetogenic DQ8 and murine I-Ag7 molecules show common sequence specificity. J. Clin. Invest. 115: 2268-2276.

Corper, A. L., T. Stratmann, V. Apostolopoulos, C. A. Scott, K. C. Garcia, A. S. Kang, I. A. Wilson, L. Teyton. 2000. A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes. Science 288: 505-511.

Lee, K. H., K. W. Wucherpfennig, D. C. Wiley. 2001. Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes. Nat. Immunol. 2: 501-507.

Suri, A., J. J. Walters, O. Kanagawa, M. L. Gross, E. R. Unanue. 2003. Specificity of peptide selection by Ag-presenting cells homozygous or heterozygous for expression of class II MHC molecules: the lack of competition. Proc. Natl. Acad. Sci. USA 100: 5330-5335.

Munz, C., M. Hofmann, K. Yoshida, A. K. Moustakas, H. Kikutani, S. Stevanovic, G. K. Papadopoulos, H. G. Rammensee. 2002. Peptide analysis, stability studies, and structural modeling explain contradictory peptide motifs and unique properties of the NOD mouse MHC class II molecule H2-Ag7. Eur. J. Immunol. 32: 2105-2116.

Zavala-Ruiz, Z., I. Strug, M. W. Anderson, J. Gorski, L. J. Stern. 2004. A polymorphic pocket at the P10 position contributes to peptide binding specificity in class II MHC proteins. Chem. Biol. 11: 1395-1402.

Carson, R. T., K. M. Vignali, D. L. Woodland, D. A. Vignali. 1997. T cell receptor recognition of MHC class II-bound peptide flanking residues enhances immunogenicity and results in altered TCR V region usage. Immunity 7: 387-399.

Velazquez, C., I. Vidavsky, K. van der Drift, M. L. Gross, E. R. Unanue. 2002. Chemical identification of a low abundance lysozyme peptide family bound to I-Ak histocompatibility molecules. J. Biol. Chem. 277: 42514-42522.

Alleva, D. G., A. Gaur, L. Jin, D. Wegmann, P. A. Gottlieb, A. Pahuja, E. B. Johnson, T. Motheral, A. Putnam, P. D. Crowe, et al 2002. Immunological characterization and therapeutic activity of an altered-peptide ligand, NBI-6024, based on the immunodominant type 1 diabetes autoantigen insulin B-chain (9–23) peptide. Diabetes 51: 2126-2134.

Liu, G. Y., D. C. Wraith. 1995. Affinity for class II MHC determines the extent to which soluble peptides tolerize autoreactive T cells in naive and primed adult mice: implications for autoimmunity. Int. Immunol. 7: 1255-1263.

Liu, G. Y., P. J. Fairchild, R. M. Smith, J. R. Prowle, D. Kioussis, D. C. Wraith. 1995. Low avidity recognition of self-antigen by T cells permits escape from central tolerance. Immunity 3: 407-415.

Carrasco-Marin, E., J. Shimizu, O. Kanagawa, E. R. Unanue. 1996. The class II MHC I-Ag7 molecules from nonobese diabetic mice are poor peptide binders. J. Immunol. 156: 450-458.

Kanagawa, O., S. M. Martin, B. A. Vaupel, E. Carrasco-Marin, E. R. Unanue. 1998. Autoreactivity of T cells from nonobese diabetic mice: an I-Ag7-dependent reaction. Proc. Natl. Acad. Sci. USA 95: 1721-1724.

Fairchild, P. J., R. Wildgoose, E. Atherton, S. Webb, D. C. Wraith. 1993. An autoantigenic T cell epitope forms unstable complexes with class II MHC: a novel route for escape from tolerance induction. Int. Immunol. 5: 1151-1158.

Seamons, A., J. Sutton, D. Bai, E. Baird, N. Bonn, B. F. Kafsack, J. Shabanowitz, D. F. Hunt, C. Beeson, J. Goverman. 2003. Competition between two MHC binding registers in a single peptide processed from myelin basic protein influences tolerance and susceptibility to autoimmunity. J. Exp. Med. 197: 1391-1397.

Martinez, N. R., P. Augstein, A. K. Moustakas, G. K. Papadopoulos, S. Gregori, L. Adorini, D. C. Jackson, L. C. Harrison. 2003. Disabling an integral CTL epitope allows suppression of autoimmune diabetes by intranasal proinsulin peptide. J. Clin. Invest. 111: 1365-1371.

McInerney, M. F., J. C. Flynn, P. J. Goldblatt, S. M. Najjar, R. S. Sherwin, C. A. Janeway, Jr. 1996. High density insulin receptor-positive T lymphocytes from nonobese diabetic mice transfer insulitis and diabetes. J. Immunol. 157: 3716-3726.

Maynard, J., K. Petersson, D. H. Wilson, E. J. Adams, S. E. Blondelle, M. J. Boulanger, D. B. Wilson, K. C. Garcia. 2005. Structure of an autoimmune T cell receptor complexed with class II peptide-MHC: insights into MHC bias and antigen specificity. Immunity 22: 81-92.

Hahn, M., M. J. Nicholson, J. Pyrdol, K. W. Wucherpfennig. 2005. Unconventional topology of self peptide-major histocompatibility complex binding by a human autoimmune T cell receptor. Nat. Immunol. 6: 490-496.

Li, Y., Y. Huang, J. Lue, J. A. Quandt, R. Martin, R. A. Mariuzza. 2005. Structure of a human autoimmune TCR bound to a myelin basic protein self-peptide and a multiple sclerosis-associated MHC class II molecule. EMBO J. 24: 2968-2979.